LOGIN
Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis
April 2021
Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparison of Botulinum Toxin A, Corticosteroid, and Anesthetic Injection for Plantar Fasciitis
Foot Ankle Int. 2021 Mar;42(3): 305-313.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seventy-one patients with ≥2 months of persisting heel pain at the origin of the plantar fascia unresponsive to conventional therapies were randomized to receive a single injection of ropivacaine (5 mL; n=23), an intra-lesional injection of betamethasone sodium phosphate (1 mL; n=25), or an intralesional injection of 200 U of botulinum toxin A (BoNT-A; n=23) injection, administered using ultrasoun...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.